Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01729923
Title A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer
Acronym ADAPT
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.